Heated Vest for Persons With Spinal Cord Injury
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03662308 |
Recruitment Status :
Completed
First Posted : September 7, 2018
Last Update Posted : November 25, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinal Cord Injuries | Device: Heated Vest Device: Non-Heated Vest | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 17 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Intervention Model Description: | After the heated vest has 1) been fully bench-tested and 2) satisfied safety and tolerability testing in able-bodied subjects, it will be tested in persons with tetraplegia using a crossover design with the order of the two visits randomized.
|
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Developing a Feedback-Controlled Heated Vest to Address Thermoregulatory Dysfunction in Persons With Spinal Cord Injury |
Actual Study Start Date : | February 25, 2020 |
Actual Primary Completion Date : | October 31, 2022 |
Actual Study Completion Date : | October 31, 2022 |

Arm | Intervention/treatment |
---|---|
Heated Vest Safety & Comfort (able-bodied subjects)
Able-bodied controls will be fitted with an appropriately sized heated vest, while wearing only a standard cotton T-shirt and shorts, and will remain seated in a wheelchair. Subjects will be transferred to a pre-cooled (18 degrees C) thermal chamber and data will be collected for 2 hours with the heated vest on full power. Outcome Variables for Visit 1: Skin thermocouple temperatures, subjective ratings of thermal sensation.
|
Device: Heated Vest
Heated vest that regulates its heat output based on the user's skin, the user's core temperature, and the ambient temperature
Other Name: Feedback-controlled heated vest |
Experimental: Heated Vest Efficacy (persons with tetraplegia)
Subjects with tetraplegia, while seated and wearing only a standard cotton T-shirt and shorts, will be fitted with an appropriately sized heated vest. Subjects will be transferred to a pre-cooled (18 degrees C) thermal chamber and data will be collected for up to 2 hours with the self-regulating heated vest. Primary Dependent variables: core body temperature (Tcore), cognitive performance, and thermal comfort.
|
Device: Heated Vest
Heated vest that regulates its heat output based on the user's skin, the user's core temperature, and the ambient temperature
Other Name: Feedback-controlled heated vest |
Active Comparator: Non-Heated Vest control condition (persons with tetraplegia)
The same subjects with tetraplegia from the experimental arm, while seated and wearing only a standard cotton T-shirt and shorts, will be fitted with an appropriately sized, similarly insulated, but non-heated vest (control condition). Subjects will be transferred to a pre-cooled (18 degrees C) thermal chamber and data will be collected for up to 2 hours with the non-heated vest. Primary Dependent variables: core body temperature (Tcore), cognitive performance, and thermal comfort.
|
Device: Non-Heated Vest
A similarly insulated (compared to the experimental vest), but non-heated vest
Other Name: Active comparator vest, control condition |
- Change in Core Body Temperature (Tcore) [ Time Frame: Visits 2 & 3 (subjects with tetraplegia only): Continuously throughout baseline & Thermal Challenge (2 hrs) periods. The change in Tcore from baseline to the end of Thermal Challenge will be determined. ]Tcore will be continuously monitored throughout baseline and thermal challenge periods (with heated & non-heated vests) by a TX-2 Rectal probe and Iso-Thermex Multichannel Thermometer (Columbus Instruments, Columbus, OH). The probe will be placed 10 cm beyond the anal sphincter.
- Change in Cognitive Performance: WAIS-IV [ Time Frame: Visits 2 & 3 (subjects with tetraplegia only): At the end baseline (at 15 min) & end of Thermal Challenge (at 120 min) periods. The change in cognitive performance from baseline to the end of Thermal Challenge will be determined. ]
The cognitive battery will be administered once at BL and once after Thermal Challenge in persons with tetraplegia only (Visits 2 & 3). Testing conditions will be identical, quiet, and distraction-free. Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV): Subjects will be asked to repeat 2-9 numbers forward, backward and in ascending order to assess attention, processing speed, and working memory.
Each assessment requires 10 min.
- Change in Cognitive Performance: Delayed Recall [ Time Frame: Visits 2 & 3 (subjects with tetraplegia only): At the end baseline (at 15 min) & end of Thermal Challenge (at 120 min) periods. The change in cognitive performance from baseline to the end of Thermal Challenge will be determined. ]
Delayed Recall section of the Montreal Cognitive Assessment (MoCA): Subjects will be asked to repeat 5 simple words immediately and then recall them after a 5-minute delay to assess working memory.
Each assessment requires 6 min.
- Change in Cognitive Performance: Stroop [ Time Frame: Visits 2 & 3 (subjects with tetraplegia only): At the end baseline (at 15 min) & end of Thermal Challenge (at 120 min) periods. The change in cognitive performance from baseline to the end of Thermal Challenge will be determined. ]
Stroop Color and Word: Subjects will be asked to read words of colors, colors of fonts to assess attention and processing speed; color of fonts of words which describe conflicting colors to assess response inhibition (executive functioning). Subjects will practice each of the assessments for approximately 10 seconds prior to the actual test to ensure understanding of the instructions.
Each assessment requires 4 min.
- Change in Thermal Comfort (TC) [ Time Frame: Visits 1, 2, & 3 (all subjects): During baseline & every 10 minutes throughout Thermal Challenge (2 hrs). The change in TC from baseline to the end of Thermal Challenge will be determined. ]
Thermal Comfort will be measured every 10 minutes throughout BL and thermal challenge periods by the Zhang 6-point thermal comfort scale: +3 (very comfortable), +2 (comfortable), +1 (just comfortable), -1 (just uncomfortable), -2 (uncomfortable), and -3 (very uncomfortable). A greater frequency of +1, +2, and +3 scores are considered more desirable than -1, -2, and -3 scores during the Thermal Challenge.
Each assessment requires only the time needed for the subject to respond (typically less than 10 seconds).
- Change in Skin Temperature (Tsk) under the heated vest [ Time Frame: Visits 2 & 3 (all subjects): Continuously throughout baseline (15 min) & Thermal Challenge (2 hrs) periods. The change in Tsk from baseline to the end of Thermal Challenge will be determined. ]Skin thermocouples (TX-4 Skin Surface probes, Columbus Instruments, Columbus, OH) will be taped to 12 sites on the anterior trunk. Tsk data will be collected continuously throughout the baseline (BL) and Thermal Challenge periods. All areas under the vest will have skin temperatures less than or equal to 39 degrees C.
- Change in Thermal Sensation (TS) [ Time Frame: Visit 1 (able-bodied subjects only): During baseline & every 10 minutes throughout Thermal Challenge (2 hrs). The change in TS from baseline to the end of Thermal Challenge will be determined. ]
Thermal sensation will be measured on the Zhang 9-point Thermal Sensation scale: +4 (very hot), +3 (hot), +2 (warm), +1 (slightly warm), 0 (neutral), -1 (slightly cool), -2 (cool), -3 (cold), and -4 (very cold). TS should be no greater than "warm" this would include identification of "hot spots".
Each assessment requires only the time needed for the subject to respond (typically less than 10 seconds).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 68 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Subjects with spinal cord injury (SCI) and able-bodied subjects will be recruited according to the following criteria:
- Duration of injury 1 year
- Neurological Level of SCI [C3-T1]; American Spinal Injury Association (ASIA) Impairment Scale (AIS) A & B
-
Euhydration
- Subjects will be instructed to avoid caffeine and alcohol
- maintain normal salt and water intake
- avoid strenuous exercise for 24 hours prior to study
Exclusion Criteria:
- Known heart, kidney, peripheral vascular or cerebrovascular disease
- High blood pressure
- History of Traumatic Brain Injury (TBI) or diagnosed cognitive impairment
- Untreated thyroid disease
- Diabetes mellitus
- Acute illness or infection
- Dehydration
- Smoking
- Pregnant women
- BMI>30 kg/m2
- Broken, inflamed, or otherwise fragile skin

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03662308
United States, New York | |
James J. Peters VA Medical Center, Bronx, NY | |
Bronx, New York, United States, 10468 |
Principal Investigator: | John Philip Handrakis, PT DPT EdD | James J. Peters Veterans Affairs Medical Center |
Publications:
Responsible Party: | VA Office of Research and Development |
ClinicalTrials.gov Identifier: | NCT03662308 |
Other Study ID Numbers: |
B2884-P 1I21RX002884-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | September 7, 2018 Key Record Dates |
Last Update Posted: | November 25, 2022 |
Last Verified: | November 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
Hypothermia Body Temperature Regulation Cognition |
Spinal Cord Injuries Wounds and Injuries Spinal Cord Diseases |
Central Nervous System Diseases Nervous System Diseases Trauma, Nervous System |